Nacuity Pharmaceuticals raised $12.89 million to advance drug candidates that target ocular oxidative stress in retinitis pigmentosa and other rare neurological disorders, enabling clinicians and patients to access improved therapeutic options and preserve vision.
All entries for: Nacuity Pharmaceuticals
September 13, 2025
Nacuity Pharmaceuticals
Investment
Nacuity Pharmaceuticals raised $4.5 million to advance drug candidates that target ocular oxidative stress in retinitis pigmentosa and other rare neurological disorders, enabling clinicians and patients to access improved therapeutic options and preserve vision.
Disease Area: Rare Diseases